Prescription Drugs · Vaccines
GSK revenue, results and funding
GSK filed revenue of £32.7B for 2025.
Data updated Nov 20, 2026 · Back to the company report
£32.7BRevenue, 2025
£5.7BNet income, 2025
99,300Employees, 2016
GSKLondon Stock Exchange
Results by year
| Year | Revenue | Net income | Total assets | Employees | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_DIVIDENDS | LANG_CR_S_M_BUYBACKS | LANG_CR_S_M_CAPEX | LANG_CR_S_M_STAFF_COSTS | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT | LANG_CR_S_M_ACQUISITIONS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | £32.7B | £5.7B | £61.1B | – | £1.2B | £1.1B | £2.6B | £1.4B | £1.3B | £8.8B | £390M | £7.5B | £7.9B | £3.4B | £14.7B | £1.7B |
| 2024 | £31.4B | £2.6B | £59.5B | – | £1.3B | £526M | £2.4B | £0 | £1.4B | £8.8B | £347M | £6.4B | £4B | £3.9B | £14.6B | £805M |
| 2023 | £30.3B | £4.9B | £59B | – | £1.3B | £756M | £2.2B | £0 | £1.3B | £8.5B | £321M | £6.2B | £6.7B | £2.9B | £15.2B | £1.5B |
| 2022 | £29.3B | £15B | £60.1B | – | £1.3B | £707M | £3.5B | – | £1.1B | £7.7B | £314M | £5.5B | £6.4B | £3.7B | £17B | £3.1B |
| 2021 | £24.7B | £4.4B | £79.1B | – | £1.3B | £83M | £4B | – | £950M | £7.7B | £345M | £5B | £4.4B | £4.3B | £20.6B | £0 |
| 2020 | £24.4B | £5.7B | £80.4B | – | £1.7B | £67M | £4B | – | £989M | £8.6B | £330M | £4.8B | £6B | £6.3B | £23.4B | £0 |
| 2019 | £33.8B | £4.6B | £79.7B | – | £1.5B | £953M | £4B | – | £1.3B | £9.9B | £432M | £4.6B | £7B | £4.7B | £23.6B | £3.6B |
| 2018 | £30.8B | £3.6B | £58.1B | – | £1.3B | £754M | £3.9B | – | £1.3B | £9.4B | £393M | £3.9B | £5.5B | £3.9B | £20.3B | £0 |
| 2017 | £30.2B | £1.5B | £56.4B | – | £1.3B | £1.4B | −£3.9B | – | £1.5B | £9.1B | £347M | £4.5B | £4.1B | £3.8B | £14.3B | – |
| 2016 | £27.9B | £912M | £59.1B | 99,300 | £1.6B | £877M | £4.9B | – | £1.5B | £8.2B | £338M | £3.6B | £2.6B | £4.9B | £14.7B | −£17M |
| 2015 | £23.9B | £8.4B | – | – | £2.1B | £2.2B | £3.9B | – | £1.4B | £8B | £349M | £3.6B | £10.3B | £5.8B | – | £3.2B |
| 2013 | – | – | – | 99,541 | – | – | – | – | – | – | – | – | – | – | – | – |
Sources: SEC, Wikidata
How to cite
GSK, Financials. Alion, Nov 20, 2026. https://alion.io/company/gsk/financials
